Calamos Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-110,000	Closed	-$8.48M	–	1163
2022 Q1	$8.48M	Buy	110,000 +16,000	+17%	+$1.34M	0.03%	566
2021 Q4	$8.3M	Buy	+94,000	New	+$7.76M	0.03%	558
2020 Q3	–	Sell	-159,791	Closed	-$16.2M	–	710
2020 Q2	$19.7M	Sell	159,791 -1,500	-0.9%	-$149K	0.14%	187
2020 Q1	$13.6M	Buy	+161,291	New	+$13.9M	0.11%	221
2017 Q1	–	Sell	-292,378	Closed	-$24.2M	–	621
2016 Q4	$24.2M	Sell	292,378 -48,908	-14%	-$4.21M	0.19%	156
2016 Q3	$31.6M	Buy	+341,286	New	+$32.1M	0.23%	147
2014 Q3	–	Sell	-8,470	Closed	-$527K	–	643
2014 Q2	$527K	Buy	8,470 +2,070	+32%	+$125K	﹤0.01%	598
2014 Q1	$437K	Sell	6,400 -1,900	-23%	-$140K	﹤0.01%	595
2013 Q4	$583K	Buy	8,300 +3,900	+89%	+$265K	﹤0.01%	583
2013 Q3	$318K	Sell	4,400 -5,300	-55%	-$352K	﹤0.01%	585
2013 Q2	$541K	Buy	+9,700	New	+$604K	﹤0.01%	525